Congressional Letter Challenging Indian IP Policy Falsely Condemns Protectionism While Trouble-Shooting for Big Pharma
On June 18, 2013, 170 Members of Congress wrote to President Obama complaining about Indian trade policy and more particularly…
The Interaction of the Proposed LDC Extension Request and the 2016 Pharmaceutical Product Extension
The current request of WTO LDC Members for an unconditional extension of the time period within which they must become…
Global Academics’ Expert Letter on LDC Extension
Over 130 academics from around the world have signed a letter supporting the unconditional extension of the transition period within…
Investors’ IP Rights Unbound: The Danger of Investment Clauses to Access to Medicines
[Cross posted from Equilibri.net] Although access to medicines activists have been wise to focus our attention intently on convincing low-…
Legal Academics’ Expert Letter on LDCs’ TRIPS Extension Request
Several of IP justice academics are soliciting signatures from legal and other academics around the world who focus on human…
Debunking Pharma’s Cant Against the Novartis Judgment: Myth and Fact
Novartis, its fellow Big Pharma multinationals, Chambers of Commerce, and PhRMA have all roundly denounced India’s Supreme Court’s decision invalidating…
Analysis: India’s Supreme Court Upholds Strict Patent Standards and Patients’ Right to Access to Affordable Medicines; Court dismisses unmeritorious court challenge by drug giant Novartis
In a stunning victory for poor patients throughout the developing world, the Indian Supreme Court today ruled against a Novartis…
Detailed Analysis of the Medicines Patent Pool-ViiV Pediatric ARV License and Memorandum of Understanding
Introduction: On February 27, the Medicines Patent Pool (MPP) and ViiV Healthcare UK Limited (ViiV) announced their License Agreement on…
LDCs collectively request an indefinite extension of their TRIPS-compliance transition periods
Led by Haiti, least developed country Members of the WTO have on November 5 filed a so-called “properly motivated” request…
Indonesian Compulsory Licenses Show Values of Pro-Access TRIPS-Flexibility Terms in Voluntary Licenses
It is a tremendous victory for people living with HIV in Indonesia that it has issued new compulsory licenses on…
Intellectual Property Policy Incoherence at the African Union Threatens Access to Medicines
Proposed Pan-African IP Organization a Terrible Idea In a stunning development, following an obscure vote of Heads of State at…
Leaked TPP Investment Chapter Presents a Grave Threat to Access to Medicines
The leaked Trans-Pacific Partnership Investment Chapter has been analyzed extensively with respect to its dangerous intellectual property protections and enhanced…